CCACX
Price
$21.75
Change
+$0.18 (+0.83%)
Updated
Dec 20 closing price
FSMDX
Price
$34.10
Change
-$0.24 (-0.70%)
Updated
Dec 20 closing price
Ad is loading...

CCACX vs FSMDX

Header iconCCACX vs FSMDX Comparison
Open Charts CCACX vs FSMDXBanner chart's image
Calvert Mid-Cap C
Price$21.75
Change+$0.18 (+0.83%)
VolumeN/A
CapitalizationN/A
Fidelity Mid Cap Index
Price$34.10
Change-$0.24 (-0.70%)
VolumeN/A
CapitalizationN/A
CCACX vs FSMDX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CCACX vs. FSMDX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCACX is a StrongBuy and FSMDX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 39.6B vs. CCACX (241M). FSMDX pays higher dividends than CCACX: FSMDX (1.28) vs CCACX (0.00). CCACX was incepted earlier than FSMDX: CCACX (30 years) vs FSMDX (13 years). CCACX is a more actively managed with annual turnover of: 27.00 vs. FSMDX (9.00). FSMDX has a lower initial minimum investment than CCACX: FSMDX (0) vs CCACX (1000). FSMDX annual gain was more profitable for investors over the last year : 16.00 vs. CCACX (3.03). FSMDX return over 5 years is better than : 54.54 vs. CCACX (-7.01).
CCACXFSMDXCCACX / FSMDX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years13 years-
Gain YTD2.44915.18516%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets241M39.6B1%
Annual Yield % from dividends0.001.28-
Returns for 1 year3.0316.0019%
Returns for 3 years-6.6514.12-47%
Returns for 5 years-7.0154.54-13%
Returns for 10 years-16.67113.54-15%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BTCT4.990.62
+14.19%
BTC Digital Ltd
PLAY27.401.20
+4.58%
Dave & Buster's Entertainment
BFIN12.680.29
+2.34%
BankFinancial Corp
NPKI7.330.09
+1.24%
NPK International Inc
SRPT118.97-0.50
-0.42%
Sarepta Therapeutics